Does depressed persons with non-cardiovascular morbidity have a higher risk of CVD? A population-based cohort study

Aysha Almas1,2, Jette Moller3, Romaina Iqbal4

  • 1Department of Public Health Sciences, Karolinska Institutet, Widerströmska huset, 3rd floor, Tomtebodavägen 18 A, 171 77, Stockholm, Sweden. aysha.almas@aku.edu.

Insights

Depression combined with other health problems significantly elevates the risk of cardiovascular disease (CVD). This comorbidity poses a greater future CVD risk than either condition alone.

Area of Science:

  • Cardiology
  • Psychiatry
  • Epidemiology

Background:

  • Depression frequently co-occurs with non-cardiovascular conditions.
  • The impact of this comorbidity on cardiovascular disease (CVD) risk is not well-established.
  • Understanding this interaction is crucial for comprehensive patient care.

Purpose of the Study:

  • To investigate whether non-cardiovascular morbidity modifies the association between depression and future CVD risk.
  • To quantify the combined effect of depression and non-cardiovascular morbidity on CVD incidence.

Main Methods:

  • Utilized data from the longitudinal PART study (Mental Health, Work and Relationships).
  • Included 10,443 adults aged 20-64 years.
  • Assessed depression via Major Depression Inventory (MDI), non-cardiovascular morbidity via self-report, and CVD outcomes via the National Patient Register.

Main Results:

  • Both depression (HR 1.5) and non-cardiovascular morbidity (HR 2.0) independently increased future CVD risk.
  • The combination of depression and non-cardiovascular morbidity showed a significantly higher risk (HR 2.1) for future CVD.
  • These associations remained significant after adjusting for demographics, socioeconomic status, hypertension, diabetes, and lifestyle factors.

Conclusions:

  • Individuals with both depression and non-cardiovascular morbidity face a substantially elevated risk of developing cardiovascular disease.
  • This highlights the importance of addressing comorbid conditions in managing depression to mitigate cardiovascular risks.
Abstract

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Cardiovascular System Abnormal Findings I: Inspection and Palpation01:29

Cardiovascular System Abnormal Findings I: Inspection and Palpation

In a cardiovascular examination, inspection and palpation are crucial for identifying abnormalities.
Abnormal findings observed during an inspection
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...